Literature DB >> 19100599

Operative versus nonoperative management of ureteropelvic junction obstruction in children.

Jonathan E Heinlen1, C Scott Manatt, Brianna C Bright, Bradley P Kropp, Jeffrey B Campbell, Dominic Frimberger.   

Abstract

OBJECTIVES: To describe and validate our strategy for treating patients with ureteropelvic junction obstruction operatively or nonoperatively according to ultrasonography and nuclear renal scan findings.
METHODS: A retrospective analysis of 243 patients from 1999 to 2006 with grade 3-4 hydronephrosis was performed. Depending on the grade of hydronephrosis with parenchymal thinning on ultrasonography and renal function on the nuclear renal scan, patients were treated with immediate pyeloplasty, pyeloplasty after a period of observation, or observation only.
RESULTS: Of 243 patients, 116 were found to have UPJO as determined by a half-life >20 minutes. The mean follow-up was 24.0 months (range 3-69). Immediate pyeloplasty was performed in 32 children, and 84 were treated conservatively. Crossover from observation to surgery occurred in 47 children. In the immediate pyeloplasty group, the mean pre- and postoperative differential function was 30.4% and 38.8%, respectively (P < .0001). In the observation-only group (n = 37), the initial mean renal function was 41.4% and stayed stable throughout the follow-up period, at a mean of 43.2% (P = .2764). In the delayed pyeloplasty group (n = 47), the initial mean renal function was 35.9% and increased to a mean of 41.6% after intervention (P = .0003). The median improvement of hydronephrosis on ultrasonography for those who underwent immediate surgery from before to after the intervention was from grade 4 to grade 3 (P < .0001). For those not undergoing surgery, it improved from grade 4 to grade 2.25 (P = .0026) and for those who underwent delayed surgery, from grade 4 to 3 (P = .0003).
CONCLUSIONS: According to our findings, the serial ultrasonography findings and initial renal function on nuclear renal scan are better indicators than the half-life alone for determining whether pyeloplasty is indicated.

Entities:  

Mesh:

Year:  2008        PMID: 19100599     DOI: 10.1016/j.urology.2008.08.512

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  13 in total

1.  Delayed redo pyeloplasty fails to recover lost renal function after failed pyeloplasty: early sonographic changes that correlate with a loss of differential renal function.

Authors:  Doo Yong Chung; Chang Hee Hong; Young Jae Im; Yong Seung Lee; Sang Woon Kim; Sang Won Han
Journal:  Korean J Urol       Date:  2015-01-30

2.  The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants.

Authors:  Antigoni Pavlaki; Nikoleta Printza; Evangelia Farmaki; Stella Stabouli; Anna Taparkou; Magdalini Sterpi; John Dotis; Fotios Papachristou
Journal:  Pediatr Nephrol       Date:  2019-10-13       Impact factor: 3.714

3.  Current radiological techniques used to evaluate unilateral partial ureteral obstruction: an experimental rabbit study.

Authors:  Mehmet Yazıcı; Suleyman Celebi; Özgür Kuzdan; Hüseyin Koçan; Halil Suat Ayyıldız; İlkay Koray Bayrak; Meltem Ceyhan Bilgici; Oktay Yapıcı; Mehmet Kefeli; Ender Arıtürk
Journal:  Int Urol Nephrol       Date:  2015-05-06       Impact factor: 2.370

Review 4.  Primary non-surgical management of unilateral ureteropelvic junction obstruction in children: a systematic review.

Authors:  Marcus Weitz; Maria Schmidt; Guido Laube
Journal:  Pediatr Nephrol       Date:  2016-12-23       Impact factor: 3.714

5.  Matrix metalloproteinases in ureteropelvic junction obstruction.

Authors:  A Pavlaki; N Printza; E Farmaki; S Stabouli; A Taparkou; J Dotis; F Papachristou
Journal:  Hippokratia       Date:  2017 Jul-Sep       Impact factor: 0.471

6.  Urinary proteome analysis identifies infants but not older children requiring pyeloplasty.

Authors:  Jens Drube; Petra Zürbig; Eric Schiffer; Esther Lau; Benno Ure; Sylvia Glüer; Martin Kirschstein; Lars Pape; Stéphane Decramer; Jean-Loup Bascands; Joost P Schanstra; Harald Mischak; Jochen H H Ehrich
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

7.  Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy.

Authors:  Chrystelle Lacroix; Cécile Caubet; Anne Gonzalez-de-Peredo; Benjamin Breuil; David Bouyssié; Alexandre Stella; Luc Garrigues; Caroline Le Gall; Anthony Raevel; Angelique Massoubre; Julie Klein; Stéphane Decramer; Frédérique Sabourdy; Flavio Bandin; Odile Burlet-Schiltz; Bernard Monsarrat; Joost-Peter Schanstra; Jean-Loup Bascands
Journal:  Mol Cell Proteomics       Date:  2014-09-09       Impact factor: 5.911

8.  Is a Reassuring MAG-3 Diuretic Renal Scan Really Reassuring?

Authors:  Lauren N Wood; Colby E Souders; Andrew L Freedman
Journal:  Curr Urol       Date:  2015-11-10

9.  Diagnostic accuracy of Onen's Alternative Grading System combined with Doppler evaluation of ureteral jets as an alternative in the diagnosis of obstructive hydronephrosis in children.

Authors:  Jose de Bessa; Cicilia M Rodrigues; Maria Cristina Chammas; Eduardo P Miranda; Cristiano M Gomes; Paulo R Moscardi; Marcia C Bessa; Carlos A Molina; Ricardo B Tiraboschi; Jose M Netto; Francisco T Denes
Journal:  PeerJ       Date:  2018-05-18       Impact factor: 2.984

10.  Revised guidelines on management of antenatal hydronephrosis.

Authors:  A Sinha; A Bagga; A Krishna; M Bajpai; M Srinivas; R Uppal; I Agarwal
Journal:  Indian J Nephrol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.